Direct-to-consumer platforms for prescription medicines are growing, but patients need support to use them as part of a ...
Sanofi’s Infilbray is now approved for treating Gaucher disease type 3. The brain-penetrating small molecule is the first FDA ...
Another panelist — Dr. Warris Bokhari, CEO of Claimable — agreed that it should be a qualified human making the decision on ...
Sickle cell disease and beta thalassemia are the startup’s lead indications. While gene therapies are available for both ...
Health systems are jumping to integrate AI into clinicians' everyday tools. When those platforms also offer the medical ...
By applying proven and enforceable guardrails, coupled with smart financial incentives, we can ensure AI elevates medical ...
Bayer’s asundexian, brand name Sunharbo, is the first FDA-approved drug in a new class cardiovascular medicines Approval of ...
MedCity News Editor-in-Chief Arundhati Parmar and Reporter Marissa Plescia interviewed a wide range of healthcare startups ...
Oyster Therapeutics’ lead program penetrates the brain to degrade pathological tau associated with Alzheimer’s disease. Eli ...
News emerging during the annual HLTH conference, including ones from Abridge, reflects the growing use of AI in clinical ...
The AMA and 61 healthcare organizations are urging Congress to advance four Medicare reforms to stabilize physician payments and protect patient access to care.
Nkarta will present initial clinical data for its natural killer cell therapy in two disorders, myositis and systemic ...